Dextromethorphan Polistirex Extended Release Suspension
Product Images NDC 45802-433

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Dextromethorphan Polistirex Extended Release (NDC 45802-433). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Padagis-dextromethorphan-polistirex-orange-carton-image.jpg (Padagis Dextromethorphan Polistirex Orange Carton Image)

The label for Dextromethorphan Polistirex Extended-Release Oral Suspension 30 mg/5 mL by Padagis Israel Pharmaceuticals Ltd features a brown bottle and an orange-flavored 3 FL OZ (89 mL) suspension. It highlights 12-hour cough relief, alcohol-free formulation, and includes dosing instructions for various age groups. The label also warns about allergic-type reactions due to sodium metabisulfite content and includes usage directions and drug facts.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.